BG43691A3 - Method for prepring of 2, 6- naphthyridine derivatives - Google Patents

Method for prepring of 2, 6- naphthyridine derivatives

Info

Publication number
BG43691A3
BG43691A3 BG8571530A BG7153085A BG43691A3 BG 43691 A3 BG43691 A3 BG 43691A3 BG 8571530 A BG8571530 A BG 8571530A BG 7153085 A BG7153085 A BG 7153085A BG 43691 A3 BG43691 A3 BG 43691A3
Authority
BG
Bulgaria
Prior art keywords
chained
straight
carbon atoms
branched alkyl
alkyl radical
Prior art date
Application number
BG8571530A
Inventor
Gerhard Satzinger
Johannes Hartenstein
Karl Mannhardt
Juergen Kleinschroth
Hartmut Osswald
Guenter Weinheimer
Edgar Fritschi
Original Assignee
Goedecke Ag,Wb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843431303 external-priority patent/DE3431303A1/en
Priority claimed from DE19853502790 external-priority patent/DE3502790A1/en
Application filed by Goedecke Ag,Wb filed Critical Goedecke Ag,Wb
Publication of BG43691A3 publication Critical patent/BG43691A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention describes 1,6-naphthyridine derivatives of the general formula: <IMAGE> wherein R1 is an unsubstituted or substituted aromtic or heteroaromatic ring, R2 is a straight-chained or branched alkyl radical containing up to four carbon atoms or a benzyl radical, R3 is a hydrogen atom, a straight-chained or branched alkyl radical or an alkoxycarbonyl radical containing up to four carbon atoms, R4 is a straight-chained or branched alkyl radical containing up to four carbons and R5 is a carbonyl group or a straight-chained, branched or cyclic alkoxycarbonyl radical which contains up to 17 carbon atoms and optionally also contains an oxygen, sulphur or nitrogen atom; as well as the pharamacologically acceptable salts thereof, which are useful for treating diseases of the blood vessels.
BG8571530A 1984-08-25 1985-08-21 Method for prepring of 2, 6- naphthyridine derivatives BG43691A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431303 DE3431303A1 (en) 1984-08-25 1984-08-25 1,6-Naphthyridine derivatives, process for their preparation and their use
DE19853502790 DE3502790A1 (en) 1985-01-29 1985-01-29 1,6-Naphthyridine derivatives, process for their preparation, and their use

Publications (1)

Publication Number Publication Date
BG43691A3 true BG43691A3 (en) 1988-07-15

Family

ID=25824189

Family Applications (1)

Application Number Title Priority Date Filing Date
BG8571530A BG43691A3 (en) 1984-08-25 1985-08-21 Method for prepring of 2, 6- naphthyridine derivatives

Country Status (22)

Country Link
US (1) US4711901A (en)
EP (1) EP0173933B1 (en)
KR (1) KR890000706B1 (en)
AT (1) ATE48276T1 (en)
AU (1) AU576887B2 (en)
BG (1) BG43691A3 (en)
CA (1) CA1263118A (en)
DE (1) DE3574471D1 (en)
DK (1) DK165247C (en)
ES (1) ES8604960A1 (en)
FI (1) FI80697C (en)
GR (1) GR852040B (en)
HU (1) HU194879B (en)
IE (1) IE58364B1 (en)
IL (2) IL75987A (en)
NO (1) NO161493C (en)
NZ (1) NZ213218A (en)
PH (4) PH21177A (en)
PL (1) PL146668B1 (en)
RO (1) RO92245B (en)
SU (1) SU1395143A3 (en)
YU (2) YU45000B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431303A1 (en) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-Naphthyridine derivatives, process for their preparation and their use
DE3906406C1 (en) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
DE3906460C1 (en) * 1989-03-01 1990-11-15 Goedecke Ag, 1000 Berlin, De
DE102006026583A1 (en) 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituted hetero-bicyclic compounds and their use
DE102006026585A1 (en) 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and their use
DE102007009494A1 (en) 2007-02-27 2008-08-28 Bayer Healthcare Ag New 1,6-naphthyridine or 8-azaquinazoline derivatives useful for treating aldosteronism, hypertension, cardiac insufficiency, myocardial infarct sequelae, liver cirrhosis, renal insufficiency and stroke
KR102527893B1 (en) * 2014-08-01 2023-05-02 바이엘 파마 악티엔게젤샤프트 Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
WO2017032673A1 (en) * 2015-08-21 2017-03-02 Bayer Pharma Aktiengesellschaft Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient
SI3337801T1 (en) * 2015-08-21 2019-08-30 Bayer Pharma Aktiengesellschaft Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and recovery of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide by electrochemical methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304914A (en) * 1980-07-07 1981-12-08 Usv Pharmaceutical Corporation Naphthyridone derivatives
DE3327650A1 (en) * 1983-07-30 1985-02-14 Gödecke AG, 1000 Berlin 1,6-NAPHTHYRIDINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST VASCULAR DISEASES

Also Published As

Publication number Publication date
DK384485A (en) 1986-02-26
NO161493C (en) 1989-08-23
NO853329L (en) 1986-02-26
YU47010B (en) 1994-11-15
PL146668B1 (en) 1989-02-28
YU45000B (en) 1991-06-30
DK384485D0 (en) 1985-08-23
SU1395143A3 (en) 1988-05-07
DK165247B (en) 1992-10-26
HU194879B (en) 1988-03-28
IL75987A (en) 1991-07-18
KR890000706B1 (en) 1989-03-27
IE852085L (en) 1986-02-25
FI80697C (en) 1990-07-10
ES8604960A1 (en) 1986-03-01
FI853233L (en) 1986-02-26
IL75987A0 (en) 1985-12-31
FI80697B (en) 1990-03-30
DE3574471D1 (en) 1990-01-04
PH23379A (en) 1989-07-26
HUT39448A (en) 1986-09-29
US4711901A (en) 1987-12-08
YU14588A (en) 1991-02-28
RO92245B (en) 1987-07-31
AU576887B2 (en) 1988-09-08
AU4662685A (en) 1986-02-27
EP0173933A1 (en) 1986-03-12
CA1263118A (en) 1989-11-21
ATE48276T1 (en) 1989-12-15
GR852040B (en) 1985-12-19
NO161493B (en) 1989-05-16
FI853233A0 (en) 1985-08-22
DK165247C (en) 1993-04-26
YU134885A (en) 1988-10-31
ES546366A0 (en) 1986-03-01
RO92245A (en) 1987-07-30
PH21177A (en) 1987-08-07
KR860001810A (en) 1986-03-22
PH24762A (en) 1990-10-01
EP0173933B1 (en) 1989-11-29
IE58364B1 (en) 1993-09-08
PL255118A1 (en) 1986-07-29
PH23411A (en) 1989-07-26
NZ213218A (en) 1990-01-29

Similar Documents

Publication Publication Date Title
JPS568361A (en) Pyroglutamic acid derivative and analogue
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
BG43691A3 (en) Method for prepring of 2, 6- naphthyridine derivatives
GR3007087T3 (en)
HUT39158A (en) Process for preparing carbacyclines and pharmaceutical compositions containing such compounds
AU591255B2 (en) New derivatives of 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidine, the process and the intermediates for their preparations, their application as medicaments and the compositions containing them
GR78773B (en)
JPS6426553A (en) Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition